M. lignano Tomo-Seq
Mlig455 transcriptome Search Regeneration Regions Sections Download

Data search


search
Exact
Search

Results for MligTC455_36185

Cluster Total UMI counts Global CPM Transcripts Categories Human homolog Annotation
MligTC455_36185 71 1.48 Mlig455_035985

Neo: -

Age: -

 KCNH7 Mlig455_035985 {REF} {Length: 3355} {Pfam: Ion transport protein [PF00520.33, score=118.6]; Ion channel [PF07885.18, score=46.2]; PAS domain [PF13426.9, score=44.5]; Cyclic nucleotide-binding domain [PF00027.31, score=43.8]; PAS fold [PF00989.27, score=22.5]; PAS fold [PF08447.14, score=21.9]} {Human: ENSG00000184611, KCNH7, potassium voltage-gated channel subfamily H member 7, [Score=795, Expect=0.0]; ENSG00000173826, KCNH6, potassium voltage-gated channel subfamily H member 6, [Score=786, Expect=0.0]; ENSG00000055118, KCNH2, potassium voltage-gated channel subfamily H member 2, [Score=773, Expect=0.0]} {Mouse: ENSMUSG00000059742, Kcnh7, potassium voltage-gated channel, subfamily H (eag-related), member 7, [Score=795, Expect=0.0]; ENSMUSG00000001901, Kcnh6, potassium voltage-gated channel, subfamily H (eag-related), member 6, [Score=794, Expect=0.0]; ENSMUSG00000038319, Kcnh2, potassium voltage-gated channel, subfamily H (eag-related), member 2, [Score=774, Expect=0.0]} {Dmel: FBgn0003353, sei, seizure, [Score=741, Expect=0.0]} {Celegans: WBGene00006830, unc-103, Potassium voltage-gated channel unc-103, [Score=714, Expect=0.0]} {Smed: dd_Smed_v6_12621_0_1, dd_Smed_v6_12621_0_1, [Score=775, Expect=0.0]} {RNA1509_16542} {RNA1310_5129.1} {RNA815_4089.1}

Cumulative graph for MligTC455_36185

Region-enriched expression

Region logFC logCPM Pvalue FDR Specificity
RegionR1 -2.886 1.487 0.61914 1.00000
RegionR2 0.286 1.487 0.76133 1.00000
RegionR3 -0.551 1.487 0.96389 1.00000
RegionR4 0.127 1.487 0.81830 1.00000
RegionR5 -1.915 1.487 0.99945 1.00000
RegionR6 1.007 1.487 0.32998 0.91830
RegionR7 2.456 1.487 0.03029 0.33093
RegionR8 1.477 1.487 0.40379 1.00000

Regeneration-enriched expression

Region logFC logCPM PValue FDR Specificity
RegenerationR1 3.938 1.487 0.51517 1.00000
RegenerationR2 0.925 1.487 0.17880 0.62083
RegenerationR3 -0.096 1.487 0.93091 1.00000
RegenerationR4 -0.371 1.487 0.70928 0.95722
RegenerationR5 1.06 1.487 0.29208 0.71982
RegenerationR6 -0.682 1.487 0.43531 0.76104
RegenerationBL 0.123 1.487 0.91708 1.00000
RegenerationTP -2.541 1.487 0.09798 0.48937


Genes with expression patterns similar to MligTC455_36185

Nr. Cluster Total UMI counts Global CPM Transcripts Categories Human homolog Σ Spearman correlations Int1 Int2 Int3 Reg1 Reg2 Reg3 Annotation
1. MligTC455_36185 71 1.48 Mlig455_035985

Neo: -

Age: -

 KCNH7 6 1.000 1.000 1.000 1.000 1.000 1.000 Mlig455_035985 {REF} {Length: 3355} {Pfam: Ion transport protein [PF00520.33, score=118.6]; Ion channel [PF07885.18, score=46.2]; PAS domain [PF13426.9, score=44.5]; Cyclic nucleotide-binding domain [PF00027.31, score=43.8]; PAS fold [PF00989.27, score=22.5]; PAS fold [PF08447.14, score=21.9]} {Human: ENSG00000184611, KCNH7, potassium voltage-gated channel subfamily H member 7, [Score=795, Expect=0.0]; ENSG00000173826, KCNH6, potassium voltage-gated channel subfamily H member 6, [Score=786, Expect=0.0]; ENSG00000055118, KCNH2, potassium voltage-gated channel subfamily H member 2, [Score=773, Expect=0.0]} {Mouse: ENSMUSG00000059742, Kcnh7, potassium voltage-gated channel, subfamily H (eag-related), member 7, [Score=795, Expect=0.0]; ENSMUSG00000001901, Kcnh6, potassium voltage-gated channel, subfamily H (eag-related), member 6, [Score=794, Expect=0.0]; ENSMUSG00000038319, Kcnh2, potassium voltage-gated channel, subfamily H (eag-related), member 2, [Score=774, Expect=0.0]} {Dmel: FBgn0003353, sei, seizure, [Score=741, Expect=0.0]} {Celegans: WBGene00006830, unc-103, Potassium voltage-gated channel unc-103, [Score=714, Expect=0.0]} {Smed: dd_Smed_v6_12621_0_1, dd_Smed_v6_12621_0_1, [Score=775, Expect=0.0]} {RNA1509_16542} {RNA1310_5129.1} {RNA815_4089.1}
2. MligTC455_31602 208 4.33 Mlig455_031241, Mlig455_031248

Neo: -

Age: -

 1.899 - - - 0.947 - 0.952

Mlig455_031241 {REF} {Length: 1588} {TRANSSPLICED} {NoTransDecoderORF} {RNA1509_36986} {RNA1310_4605} {RNA815_16115.1}

Mlig455_031248 {REF} {Length: 2570} {TRANSSPLICED} {RNA1509_36986} {RNA1310_45653} {RNA815_16115.2}
3. MligTC455_10321 235 4.89 Mlig455_004945, Mlig455_035629, Mlig455_055310

Neo: -

Age: -

 1.834 - - - 0.863 - 0.971

Mlig455_004945 {REF} {Length: 80} {NoTransDecoderORF} {RNA1509_52583} {RNA1310_6592} {RNA815_13363}

Mlig455_035629 {REF} {Length: 143} {NoTransDecoderORF} {RNA1509_52583} {RNA1310_6592} {RNA815_13363}

Mlig455_055310 {REF} {Length: 2978} {RNA1509_52583} {RNA1310_43983.1} {RNA815_13363}
4. MligTC455_09509 46 0.95 Mlig455_042043

Neo: -

Age: -

 1.802 - - - - 0.843 0.959 Mlig455_042043 {REF} {Length: 1543} {Pfam: SICA C-terminal inner membrane domain [PF12879.9, score=63.2]} {RNA1509_50446} {RNA1310_8738.1} {RNA815_21682.1}
5. MligTC455_13708 164 3.41 Mlig455_058918, Mlig455_058920

Neo: -

Age: -

 1.721 - - 0.764 - 0.957 -

Mlig455_058918 {REF} {Length: 695} {NoTransDecoderORF} {RNA1310_33077}

Mlig455_058920 {REF} {Length: 663} {NoTransDecoderORF} {RNA1310_33077}
6. MligTC455_35879 70 1.45 Mlig455_043343

Neo: -

Age: -

 NR4A3 1.708 0.753 - - - - 0.955 Mlig455_043343 {REF} {Length: 4323} {Pfam: Zinc finger, C4 type (two domains) [PF00105.20, score=109.8]} {Human: ENSG00000119508, NR4A3, nuclear receptor subfamily 4 group A member 3, [RH, Score=168, Expect=1e-44]} {Mouse: ENSMUSG00000023034, Nr4a1, nuclear receptor subfamily 4, group A, member 1, [Score=173, Expect=2e-45]; ENSMUSG00000028341, Nr4a3, nuclear receptor subfamily 4, group A, member 3, [Score=167, Expect=5e-43]} {Dmel: FBgn0014859, Hr38, Hormone receptor-like in 38, [Score=157, Expect=2e-39]} {Celegans: WBGene00003605, nhr-6, Nuclear hormone receptor family member nhr-6, [Score=148, Expect=6e-38]} {Smed: dd_Smed_v6_12229_0_1, dd_Smed_v6_12229_0_1, [Score=236, Expect=5e-66]} {RNA1509_34082, RNA1509_57832} {RNA1310_20528.1, RNA1509_57832} {RNA1509_57832, RNA815_30713}
7. MligTC455_17377 32 0.67 Mlig455_041286

Neo: -

Age: -

 1.705 - - - - 0.751 0.954 Mlig455_041286 {REF} {Length: 912} {NoTransDecoderORF} {RNA1310_106511}
8. MligTC455_28408 47 0.98 Mlig455_055493

Neo: -

Age: -

 1.7 - - 0.746 - - 0.954 Mlig455_055493 {REF} {Length: 5141} {RNA1509_42084} {RNA1310_16069} {RNA815_21447}
9. MligTC455_28130 73 1.52 Mlig455_017884

Neo: -

Age: -

 1.693 - - - 0.738 - 0.955 Mlig455_017884 {REF} {Length: 3157} {NoTransDecoderORF} {RNA1509_13222} {RNA1310_34828.2} {RNA815_11419.1}
10. MligTC455_27376 507 10.57 Mlig455_023327

Neo: -

Age: -

 1.667 0.705 - - 0.962 - - Mlig455_023327 {REF} {Length: 1687} {NoTransDecoderORF} {RNA1509_32297} {RNA1310_63447} {RNA815_9685.1}
11. MligTC455_23011 175 3.64 Mlig455_007203

Neo: -

Age: Up-Down-Up

 B4GALT1 0.991 - - - - 0.991 - Mlig455_007203 {REF} {Length: 3010} {Pfam: N-terminal region of glycosyl transferase group 7 [PF13733.8, score=131.2]; N-terminal domain of galactosyltransferase [PF02709.16, score=96.5]} {Human: ENSG00000086062, B4GALT1, beta-1,4-galactosyltransferase 1, [Score=227, Expect=4e-68]; ENSG00000117411, B4GALT2, beta-1,4-galactosyltransferase 2, [Score=227, Expect=5e-68]} {Mouse: ENSMUSG00000028413, B4galt1, UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1, [Score=232, Expect=5e-70]; ENSMUSG00000028541, B4galt2, UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2, [Score=226, Expect=2e-68]} {Dmel: FBgn0027538, beta4GalNAcTA, [Score=213, Expect=3e-63]} {Celegans: WBGene00012206, W02B12.11, N-acetyllactosamine synthase, [RH, Score=233, Expect=8e-71]} {Smed: dd_Smed_v6_13813_0_1, dd_Smed_v6_13813_0_1, [RH, Score=249, Expect=7e-78]} {RNA1310_29894} {RNA815_14604}
12. MligTC455_25374 428 8.91 Mlig455_036389, Mlig455_036390, Mlig455_036391, Mlig455_054557

Neo: -

Age: Up-Down-Up, logFC(26M/2M)=1.690

Regeneration-upregulated BL: 5.459

Regeneration-enriched BL: 5.459

 0.981 - - - - - 0.981

Mlig455_036389 {REF} {Length: 860} {NoTransDecoderORF} {RNA1509_40044} {RNA1310_33232} {RNA815_16463}

Mlig455_036390 {REF} {Length: 5024} {RNA1509_54862} {RNA1310_31416} {RNA815_5170.1}

Mlig455_036391 {REF} {Length: 3445} {RNA1509_54862} {RNA1310_31416} {RNA815_5170.1}

Mlig455_054557 {REF} {Length: 6330} {RNA1509_54862} {RNA1310_31416} {RNA815_5170.1}
13. MligTC455_22034 231 4.82 Mlig455_045938

Neo: Irradiation

Age: -

 LARP1B 0.98 - - 0.980 - - - Mlig455_045938 {REF} {Length: 6716} {TRANSSPLICED} {Pfam: La domain [PF05383.19, score=63.1]} {Human: ENSG00000138709, LARP1B, La ribonucleoprotein domain family member 1B, [Score=285, Expect=3e-81]} {Mouse: ENSMUSG00000037331, Larp1, La ribonucleoprotein domain family, member 1, [Score=328, Expect=2e-95]} {Dmel: FBgn0261618, larp, La related protein, [Score=234, Expect=1e-63]} {Celegans: WBGene00020097, larp-1, La-related protein 1, [Score=175, Expect=2e-44]} {Smed: dd_Smed_v6_1885_0_1, dd_Smed_v6_1885_0_1, [RH, Score=218, Expect=2e-58]} {RNA1509_10711, RNA1509_13373, RNA1509_27458, RNA1509_43387, RNA1509_53542, RNA1509_57067} {RNA1310_10199.1, RNA1509_13373, RNA1509_27458, RNA1509_43387, RNA1509_53542, RNA1509_57067} {RNA1509_13373, RNA1509_27458, RNA1509_43387, RNA1509_53542, RNA1509_57067, RNA815_7521.1}
14. MligTC455_14778 64 1.34 Mlig455_050609

Neo: -

Age: -

 0.979 - - - - - 0.979 Mlig455_050609 {REF} {Length: 1397} {NoTransDecoderORF} {RNA1509_18097} {RNA1310_120182} {RNA815_14810.1}
15. MligTC455_31325 78 1.62 Mlig455_026709, Mlig455_044580, Mlig455_050736, Mlig455_050745

Neo: -

Age: -

 0.979 - - - - - 0.979

Mlig455_026709 {REF} {Length: 5107} {TRANSSPLICED} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=119.6]; Endonuclease/Exonuclease/phosphatase family [PF03372.25, score=19.1]} {Smed: dd_Smed_v6_26484_0_6, dd_Smed_v6_26484_0_6, [Score=65.1, Expect=2e-12]} {RNA1509_47056} {RNA1310_5710.1} {RNA815_6291.1}

Mlig455_044580 {REF} {Length: 2183} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=80.6]} {RNA1509_47056} {RNA1310_3828} {RNA815_6291.1}

Mlig455_050736 {REF} {Length: 1564} {TRANSSPLICED} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=121.6]} {Smed: dd_Smed_v6_26484_0_6, dd_Smed_v6_26484_0_6, [Score=65.9, Expect=7e-13]} {RNA1509_47056} {RNA1310_5710.1} {RNA815_15609}

Mlig455_050745 {REF} {Length: 1565} {TRANSSPLICED} {Pfam: Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=121.6]} {Smed: dd_Smed_v6_26484_0_6, dd_Smed_v6_26484_0_6, [Score=65.9, Expect=7e-13]} {RNA1509_47056} {RNA1310_5710.1} {RNA815_15609}
16. MligTC455_15343 177 3.68 Mlig455_028996

Neo: -

Age: -

Region-enriched R8: 3.572/0.01201

 PRKG1 0.977 - - - 0.977 - - Mlig455_028996 {REF} {Length: 3220} {Pfam: Cyclic nucleotide-binding domain [PF00027.31, score=128.3]; Protein kinase domain [PF00069.27, score=57.8]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=32.8]} {Human: ENSG00000185532, PRKG1, protein kinase cGMP-dependent 1, [Score=274, Expect=2e-81]} {Mouse: ENSMUSG00000052920, Prkg1, protein kinase, cGMP-dependent, type I, [Score=273, Expect=3e-81]} {Dmel: FBgn0000721, for, foraging, [Score=286, Expect=7e-86]} {Celegans: WBGene00001173, egl-4, cGMP-dependent protein kinase egl-4, [Score=244, Expect=7e-73]} {Smed: dd_Smed_v6_16434_0_1, dd_Smed_v6_16434_0_1, [Score=326, Expect=8e-100]} {RNA1509_32231} {RNA1310_18553.1} {RNA815_13824}
17. MligTC455_23808 31 0.65 Mlig455_059306

Neo: -

Age: Down-Down-Up

 0.976 - - - - - 0.976 Mlig455_059306 {REF} {Length: 1845} {Pfam: Pacifastin inhibitor (LCMII) [PF05375.15, score=30.7]} {RNA1509_46843} {RNA1310_11232} {RNA815_41042}
18. MligTC455_47197 155 3.24 Mlig455_049096, Mlig455_049118

Neo: -

Age: -

 0.976 - - - - 0.976 -

Mlig455_049096 {REF} {Length: 3209} {Smed: dd_Smed_v6_14861_0_1, dd_Smed_v6_14861_0_1, [Score=151, Expect=1e-37]} {RNA1509_52343} {RNA1310_44918.1} {RNA815_41725}

Mlig455_049118 {REF} {Length: 3116} {Smed: dd_Smed_v6_14861_0_1, dd_Smed_v6_14861_0_1, [Score=160, Expect=1e-40]} {RNA1509_52343} {RNA1310_44918.1} {RNA815_41725}
19. MligTC455_26668 406 8.46 Mlig455_011365

Neo: -

Age: -

Regeneration-upregulated BL: 6.270

Regeneration-enriched BL: 6.270

 0.974 - - - - - 0.974 Mlig455_011365 {REF} {Length: 3699} {Pfam: Protein of unknown function (DUF1104) [PF06518.13, score=20.7]} {RNA1509_40399} {RNA1310_340.1} {RNA815_1857}
20. MligTC455_29638 106 2.21 Mlig455_018397, Mlig455_069530

Neo: -

Age: Up-Down-Down, logFC(26M/2M)=-0.617

 0.974 - - - - - 0.974

Mlig455_018397 {REF} {Length: 5881} {Pfam: DNA polymerase type B, organellar and viral [PF03175.15, score=52.2]} {Celegans: WBGene00007723, C25F9.2, [Score=171, Expect=1e-43]} {RNA1509_4648} {RNA1310_3427} {RNA815_694.1}

Mlig455_069530 {REF} {Length: 5201} {Pfam: DNA polymerase type B, organellar and viral [PF03175.15, score=144.0]} {Celegans: WBGene00007723, C25F9.2, [Score=345, Expect=2e-99]} {RNA1509_4648} {RNA1310_2280.1} {RNA815_694.2}
21. MligTC455_22617 36 0.76 Mlig455_041097

Neo: -

Age: Up-Down-Down

 0.972 - - 0.972 - - - Mlig455_041097 {REF} {Length: 3480} {Smed: dd_Smed_v6_28678_0_1, dd_Smed_v6_28678_0_1, [RH, Score=77.0, Expect=7e-15]} {RNA1310_21449}
22. MligTC455_38059 120 2.49 Mlig455_014851

Neo: -

Age: -

 0.972 - - - - - 0.972 Mlig455_014851 {REF} {Length: 6091} {RNA1509_53932} {RNA1310_7589} {RNA815_18106}
23. MligTC455_39057 57 1.18 Mlig455_013966

Neo: Int S/G2/M

Age: -

 0.972 - - - - - 0.972 Mlig455_013966 {REF} {Length: 1262} {NoTransDecoderORF} {RNA1310_104321}
24. MligTC455_28153 87 1.82 Mlig455_023355

Neo: -

Age: Down-Up-Down

 0.971 - - - - - 0.971 Mlig455_023355 {REF} {Length: 2641} {Pfam: HTH domain in Mos1 transposase [PF17906.3, score=23.0]} {RNA1509_36436} {RNA1310_24275.2} {RNA815_11419.1}
25. MligTC455_23606 40 0.83 Mlig455_045820

Neo: -

Age: Up-Down-Up, logFC(26M/2M)=0.429

 ANK2 0.969 - - - - - 0.969 Mlig455_045820 {REF} {Length: 6904} {Pfam: Ankyrin repeats (3 copies) [PF12796.9, score=588.6]; Ankyrin repeats (many copies) [PF13637.8, score=559.7]; Ankyrin repeat [PF13606.8, score=378.6]; Ankyrin repeats (many copies) [PF13857.8, score=364.4]; Ankyrin repeat [PF00023.32, score=287.1]} {Human: ENSG00000145362, ANK2, ankyrin 2, [Score=234, Expect=4e-61]} {Mouse: ENSMUSG00000032826, Ank2, ankyrin 2, brain, [Score=234, Expect=4e-62]} {Dmel: FBgn0016920, nompC, no mechanoreceptor potential C, [Score=208, Expect=1e-53]} {Celegans: WBGene00006780, unc-44, AO66 ankyrin, [Score=187, Expect=7e-48]} {Smed: dd_Smed_v6_5303_0_2, dd_Smed_v6_5303_0_2, [Score=234, Expect=2e-63]} {RNA1509_19596} {RNA1310_2241.1} {RNA815_5124}
26. MligTC455_49788 92 1.92 Mlig455_005140

Neo: -

Age: Up-Up-Down

 0.969 - - - - 0.969 - Mlig455_005140 {REF} {Length: 2173} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=64.4]; Serpentine type 7TM GPCR chemoreceptor Srw [PF10324.11, score=43.3]} {Dmel: FBgn0035385, FMRFaR, FMRFamide Receptor, [Score=52.0, Expect=5e-07]} {Smed: dd_Smed_v6_15630_0_1, dd_Smed_v6_15630_0_1, [RH, Score=170, Expect=2e-48]} {RNA1310_33798} {RNA815_26007}
27. MligTC455_11282 124 2.58 Mlig455_017457, Mlig455_030936

Neo: -

Age: Up-Down-Up, logFC(26M/2M)=0.648

 FDXACB1 0.968 - - - - - 0.968

Mlig455_017457 {REF} {Length: 3560} {Pfam: Domain of unknown function (DUF2431) [PF10354.11, score=97.3]; Ferredoxin-fold anticodon binding domain [PF03147.16, score=28.8]} {Human: ENSG00000255561, FDXACB1, ferredoxin-fold anticodon binding domain containing 1, [RH, Score=97.4, Expect=1e-20]} {Mouse: ENSMUSG00000037845, Fdxacb1, ferredoxin-fold anticodon binding domain containing 1, [RH, Score=104, Expect=4e-23]} {Celegans: WBGene00012768, eef-1B.2, Probable elongation factor 1-beta/1-delta 2, [RH, Score=54.7, Expect=1e-07]} {Smed: dd_Smed_v6_12236_0_1, dd_Smed_v6_12236_0_1, [RH, Score=98.2, Expect=2e-21]} {RNA1509_12220} {RNA1310_10541} {RNA815_15665}

Mlig455_030936 {REF} {Length: 2975} {Pfam: Domain of unknown function (DUF2431) [PF10354.11, score=97.3]; Ferredoxin-fold anticodon binding domain [PF03147.16, score=29.2]} {Human: ENSG00000255561, FDXACB1, ferredoxin-fold anticodon binding domain containing 1, [RH, Score=97.4, Expect=2e-20]} {Mouse: ENSMUSG00000037845, Fdxacb1, ferredoxin-fold anticodon binding domain containing 1, [RH, Score=104, Expect=6e-23]} {Celegans: WBGene00012768, eef-1B.2, Probable elongation factor 1-beta/1-delta 2, [RH, Score=54.7, Expect=1e-07]} {Smed: dd_Smed_v6_12236_0_1, dd_Smed_v6_12236_0_1, [RH, Score=98.2, Expect=2e-21]} {RNA1310_10541} {RNA815_15665}
28. MligTC455_31871 31 0.65 Mlig455_010813

Neo: -

Age: -

 0.967 - - - - - 0.967 Mlig455_010813 {REF} {Length: 2512} {NoTransDecoderORF} {RNA1509_46587} {RNA1310_48408.1} {RNA815_22207.1}
29. MligTC455_08216 34 0.7 Mlig455_009138

Neo: -

Age: -

 0.966 - - - - - 0.966 Mlig455_009138 {REF} {Length: 379} {NoTransDecoderORF} {RNA1310_66482.1} {RNA815_62564}
30. MligTC455_17967 3579 74.57 Mlig455_051723, Mlig455_051747

Neo: -

Age: Down-Up-Down, logFC(26M/2M)=-0.373

Region-enriched R2: 2.354/0.00024
Region-enriched R7: 1.586/0.02362
Region-enriched R6: 1.575/0.01589

 0.966 - - - - 0.966 -

Mlig455_051723 {REF} {Length: 1123} {Pfam: YqbF, hypothetical protein domain [PF14553.8, score=33.4]; Zinc-finger of nitric oxide synthase-interacting protein [PF15906.7, score=21.7]; Protein of unknown function (DUF559) [PF04480.14, score=20.6]} {RNA1509_16925} {RNA1310_34603.1} {RNA815_20381}

Mlig455_051747 {REF} {Length: 1166} {Pfam: YqbF, hypothetical protein domain [PF14553.8, score=36.0]; Zinc-finger of nitric oxide synthase-interacting protein [PF15906.7, score=25.9]; Protein of unknown function (DUF559) [PF04480.14, score=22.5]; REase_MTES_1575 [PF18741.3, score=20.8]; CW_7 repeat [PF08230.13, score=19.3]} {RNA1509_16925} {RNA1310_34603.1} {RNA815_20381}
31. MligTC455_44993 102 2.13 Mlig455_068082

Neo: -

Age: Up-Up-Down, logFC(26M/2M)=0.499

Region-enriched R4: 3.035/0.03492

 MEN1 0.966 - - - - - 0.966 Mlig455_068082 {REF} {Length: 4679} {TRANSSPLICED} {Pfam: Menin [PF05053.15, score=359.0]} {Human: ENSG00000133895, MEN1, menin 1, [RH, Score=259, Expect=6e-77]} {Mouse: ENSMUSG00000024947, Men1, multiple endocrine neoplasia 1, [RH, Score=258, Expect=2e-76]; ENSMUSG00000106695, Men1, multiple endocrine neoplasia 1, [RH, Score=258, Expect=2e-76]} {Dmel: FBgn0031885, Mnn1, Menin 1, [RH, Score=219, Expect=4e-61]} {Smed: dd_Smed_v6_11544_0_1, dd_Smed_v6_11544_0_1, [RH, Score=206, Expect=2e-56]} {RNA1509_25186} {RNA1310_10581.1} {RNA815_3602}
32. MligTC455_34065 155 3.22 Mlig455_057127

Neo: -

Age: Up-Down-Up

 0.965 - - - - - 0.965 Mlig455_057127 {REF} {Length: 9700} {RNA1509_19375, RNA1509_20753, RNA1509_27043, RNA1509_49996} {RNA1310_9943, RNA1509_20753, RNA1509_27043, RNA1509_49996} {RNA1509_20753, RNA1509_27043, RNA1509_49996, RNA815_25153}
33. MligTC455_25309 27 0.56 Mlig455_007405

Neo: -

Age: -

 0.964 - - - - - 0.964 Mlig455_007405 {REF} {Length: 5652} {RNA1509_20101} {RNA1310_66411} {RNA815_42952}
34. MligTC455_44647 489 10.19 Mlig455_006279

Neo: -

Age: -

 OXSR1 0.964 - - - - - 0.964 Mlig455_006279 {REF} {Length: 2340} {Pfam: Protein kinase domain [PF00069.27, score=128.6]; Protein tyrosine and serine/threonine kinase [PF07714.19, score=97.0]; Phosphotransferase enzyme family [PF01636.25, score=18.9]; Lipopolysaccharide kinase (Kdo/WaaP) family [PF06293.16, score=18.9]; Fungal protein kinase [PF17667.3, score=18.8]} {Human: ENSG00000172939, OXSR1, oxidative stress responsive 1, [Score=89.7, Expect=2e-18]; ENSG00000091436, MAP3K20, mitogen-activated protein kinase kinase kinase 20, [Score=87.0, Expect=1e-17]; ENSG00000135341, MAP3K7, mitogen-activated protein kinase kinase kinase 7, [Score=85.5, Expect=4e-17]} {Mouse: ENSMUSG00000036737, Oxsr1, oxidative-stress responsive 1, [Score=89.7, Expect=1e-18]; ENSMUSG00000028284, Map3k7, mitogen-activated protein kinase kinase kinase 7, [Score=85.5, Expect=3e-17]} {Dmel: FBgn0046689, Takl1, Tak1-like 1, [Score=86.7, Expect=4e-18]} {Celegans: WBGene00006971, zak-1, Mammalian ZAK kinase homolog, [Score=82.0, Expect=3e-16]} {Smed: dd_Smed_v6_2589_0_2, dd_Smed_v6_2589_0_2, [Score=100, Expect=1e-22]} {RNA1509_40362, RNA1509_48119, RNA1509_54731} {RNA1310_1875.2, RNA1509_40362, RNA1509_48119, RNA1509_54731} {RNA1509_40362, RNA1509_48119, RNA1509_54731, RNA815_820}
35. MligTC455_10554 573 11.93 Mlig455_037747, Mlig455_069922

Neo: -

Age: -

Regeneration-depleted BL: -4.357
Regeneration-depleted R6: -4.209
Regeneration-depleted R3: -4.000
Regeneration-depleted R2: -3.924
Regeneration-depleted R5: -3.923
Regeneration-depleted R4: -3.811

 0.963 - - - - - 0.963

Mlig455_037747 {REF} {Length: 601} {RNA1509_11182} {RNA1310_30933} {RNA815_1577.1}

Mlig455_069922 {REF} {Length: 929} {RNA1509_11182} {RNA1310_9907, RNA1509_11182} {RNA1509_11182, RNA815_1577.1}
36. MligTC455_16142 67 1.41 Mlig455_028937

Neo: -

Age: -

 0.963 - - - - - 0.963 Mlig455_028937 {REF} {Length: 2115} {NoTransDecoderORF} {RNA1509_53775} {RNA1310_26215.1, RNA1509_53775} {RNA1509_53775, RNA815_54266}
37. MligTC455_31201 73 1.53 Mlig455_045851, Mlig455_045867

Neo: -

Age: Up-Down-Up

 LRRC9 0.963 - - - - - 0.963

Mlig455_045851 {REF} {Length: 5484} {TRANSSPLICED} {Pfam: Leucine-rich repeat [PF14580.8, score=159.6]; Leucine Rich repeats (2 copies) [PF12799.9, score=149.6]; Leucine rich repeat [PF13855.8, score=111.6]} {Human: ENSG00000131951, LRRC9, leucine rich repeat containing 9, [RH, Score=437, Expect=1e-129]} {Mouse: ENSMUSG00000021090, Lrrc9, leucine rich repeat containing 9, [RH, Score=639, Expect=0.0]} {Dmel: FBgn0039728, CG7896, [Score=73.6, Expect=1e-12]} {Celegans: WBGene00020266, T05H4.3, [RH, Score=80.1, Expect=7e-15]} {Smed: dd_Smed_v6_14851_0_1, dd_Smed_v6_14851_0_1, [RH, Score=368, Expect=4e-108]} {RNA1509_22179} {RNA1310_1731, RNA1509_22179} {RNA1509_22179, RNA815_589.1}

Mlig455_045867 {REF} {Length: 5480} {TRANSSPLICED} {Pfam: Leucine-rich repeat [PF14580.8, score=159.3]; Leucine Rich repeats (2 copies) [PF12799.9, score=149.0]; Leucine rich repeat [PF13855.8, score=111.3]} {Human: ENSG00000131951, LRRC9, leucine rich repeat containing 9, [RH, Score=436, Expect=2e-129]} {Mouse: ENSMUSG00000021090, Lrrc9, leucine rich repeat containing 9, [RH, Score=639, Expect=0.0]} {Dmel: FBgn0039728, CG7896, [Score=74.7, Expect=6e-13]} {Celegans: WBGene00020266, T05H4.3, [RH, Score=80.1, Expect=8e-15]} {Smed: dd_Smed_v6_14851_0_1, dd_Smed_v6_14851_0_1, [RH, Score=369, Expect=2e-108]} {RNA1509_22179} {RNA1310_1731} {RNA815_589.1}
38. MligTC455_39058 37 0.77 Mlig455_039326

Neo: -

Age: -

 0.963 - - - - - 0.963 Mlig455_039326 {REF} {Length: 1252} {NoTransDecoderORF} {RNA1310_104321}
39. MligTC455_28340 55 1.14 Mlig455_034493, Mlig455_038767, Mlig455_066245

Neo: -

Age: Up-Down-Up

Region-enriched R2: 4.182/0.03406

 CHRNB3, PCDH9 0.961 - - - - - 0.961

Mlig455_034493 {REF} {Length: 1601} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=158.8]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=91.2]} {Human: ENSG00000147432, CHRNB3, cholinergic receptor nicotinic beta 3 subunit, [Score=204, Expect=4e-59]; ENSG00000117971, CHRNB4, cholinergic receptor nicotinic beta 4 subunit, [Score=202, Expect=4e-58]; ENSG00000174343, CHRNA9, cholinergic receptor nicotinic alpha 9 subunit, [Score=195, Expect=1e-55]; ENSG00000169684, CHRNA5, cholinergic receptor nicotinic alpha 5 subunit, [Score=194, Expect=2e-55]; ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=194, Expect=3e-54]} {Mouse: ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=206, Expect=5e-60]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=200, Expect=2e-57]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=190, Expect=8e-54]} {Celegans: WBGene00000050, acr-11, AcetylCholine Receptor, [Score=185, Expect=1e-52]} {Smed: dd_Smed_v6_10322_0_1, dd_Smed_v6_10322_0_1, [Score=370, Expect=4e-122]} {RNA1509_55679} {RNA1310_29798} {RNA815_45190}

Mlig455_038767 {REF} {Length: 4472} {Pfam: Cadherin domain [PF00028.19, score=325.9]; Cadherin-like [PF16184.7, score=44.8]; Cadherin-like [PF08266.14, score=40.4]} {Human: ENSG00000184226, PCDH9, protocadherin 9, [RH, Score=339, Expect=1e-98]} {Mouse: ENSMUSG00000055421, Pcdh9, protocadherin 9, [RH, Score=335, Expect=2e-97]} {Dmel: FBgn0024836, stan, starry night, [Score=248, Expect=4e-67]} {Celegans: WBGene00001475, fmi-1, FlaMIngo (Cadherin plus 7TM domain) homolog; Flamingo-like protein FMI-1, [Score=214, Expect=3e-56]} {Smed: dd_Smed_v6_11633_0_1, dd_Smed_v6_11633_0_1, [RH, Score=355, Expect=2e-105]} {RNA1509_51596} {RNA1310_4295, RNA1509_51596} {RNA1509_51596, RNA815_10391}

Mlig455_066245 {REF} {Length: 3076} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=159.0]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=105.6]} {Human: ENSG00000147432, CHRNB3, cholinergic receptor nicotinic beta 3 subunit, [Score=208, Expect=1e-60]; ENSG00000117971, CHRNB4, cholinergic receptor nicotinic beta 4 subunit, [Score=207, Expect=4e-60]; ENSG00000101204, CHRNA4, cholinergic receptor nicotinic alpha 4 subunit, [Score=202, Expect=4e-57]; ENSG00000174343, CHRNA9, cholinergic receptor nicotinic alpha 9 subunit, [Score=202, Expect=2e-58]; ENSG00000169684, CHRNA5, cholinergic receptor nicotinic alpha 5 subunit, [Score=199, Expect=3e-57]; ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=198, Expect=1e-56]} {Mouse: ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=210, Expect=2e-61]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=206, Expect=1e-59]; ENSMUSG00000027577, Chrna4, cholinergic receptor, nicotinic, alpha polypeptide 4, [Score=201, Expect=2e-56]; ENSMUSG00000029205, Chrna9, cholinergic receptor, nicotinic, alpha polypeptide 9, [Score=201, Expect=4e-58]} {Dmel: FBgn0266347, nAChRalpha4, nicotinic Acetylcholine Receptor alpha4, [Score=201, Expect=9e-58]} {Celegans: WBGene00000050, acr-11, AcetylCholine Receptor, [Score=187, Expect=3e-53]} {Smed: dd_Smed_v6_10322_0_1, dd_Smed_v6_10322_0_1, [RH, Score=424, Expect=6e-143]} {RNA1509_55679} {RNA1310_29798, RNA1509_55679} {RNA1509_55679, RNA815_45190}
40. MligTC455_32033 79 1.65 Mlig455_050881

Neo: -

Age: Down-Down-Up, logFC(26M/2M)=-0.558

 MAPK14 0.96 - - - - - 0.960 Mlig455_050881 {REF} {Length: 2379} {Pfam: Protein kinase domain [PF00069.27, score=60.5]} {Human: ENSG00000112062, MAPK14, mitogen-activated protein kinase 14, [Score=92.4, Expect=1e-21]; ENSG00000050748, MAPK9, mitogen-activated protein kinase 9, [Score=91.3, Expect=3e-21]; ENSG00000156711, MAPK13, mitogen-activated protein kinase 13, [Score=88.2, Expect=4e-20]} {Mouse: ENSMUSG00000053436, Mapk14, mitogen-activated protein kinase 14, [Score=92.0, Expect=1e-21]; ENSMUSG00000020366, Mapk9, mitogen-activated protein kinase 9, [Score=91.3, Expect=2e-21]} {Dmel: FBgn0024846, p38b, p38b MAP kinase, [Score=90.5, Expect=3e-21]} {Celegans: WBGene00004055, pmk-1, Mitogen-activated protein kinase pmk-1, [Score=86.3, Expect=6e-20]} {Smed: dd_Smed_v6_6042_0_1, dd_Smed_v6_6042_0_1, [Score=87.8, Expect=1e-20]} {RNA1509_37050} {RNA1310_4000} {RNA815_17615}
41. MligTC455_19124 68 1.41 Mlig455_056714

Neo: -

Age: Up-Down-Up

 NPFFR1 0.959 - - - - - 0.959 Mlig455_056714 {REF} {Length: 3702} {Pfam: 7 transmembrane receptor (rhodopsin family) [PF00001.23, score=113.2]; Serpentine type 7TM GPCR chemoreceptor Srsx [PF10320.11, score=23.3]} {Human: ENSG00000148734, NPFFR1, neuropeptide FF receptor 1, [Score=90.1, Expect=1e-18]; ENSG00000137252, HCRTR2, hypocretin receptor 2, [Score=87.8, Expect=6e-18]} {Mouse: ENSMUSG00000038071, Npy6r, neuropeptide Y receptor Y6, [Score=105, Expect=2e-24]} {Dmel: FBgn0037408, NPFR, Neuropeptide F receptor, [Score=131, Expect=7e-33]} {Celegans: WBGene00003808, npr-2, NeuroPeptide Receptor family, [Score=100, Expect=1e-22]} {Smed: dd_Smed_v6_26109_0_1, dd_Smed_v6_26109_0_1, [RH, Score=210, Expect=4e-61]} {RNA1509_34547} {RNA1310_9062, RNA1509_34547} {RNA1509_34547, RNA815_6805}
42. MligTC455_34066 149 3.1 Mlig455_069292

Neo: -

Age: -

 0.959 - - - - - 0.959 Mlig455_069292 {REF} {Length: 832} {NoTransDecoderORF} {RNA1509_20753} {RNA1310_16791} {RNA815_12674.1}
43. MligTC455_24711 46 0.96 Mlig455_015705

Neo: -

Age: -

Regeneration-upregulated BL: 6.967

Regeneration-enriched BL: 6.967

 0.958 - - - - - 0.958 Mlig455_015705 {REF} {Length: 1380} {NoTransDecoderORF} {RNA1509_40708} {RNA1310_77515} {RNA815_26884}
44. MligTC455_42682 45 0.93 Mlig455_010400

Neo: -

Age: -

 0.958 - - - - - 0.958 Mlig455_010400 {REF} {Length: 1751} {NoTransDecoderORF} {RNA1509_58929} {RNA1310_128448} {RNA815_10390}
45. MligTC455_18401 44 0.92 Mlig455_060625

Neo: -

Age: -

 0.956 - - - - - 0.956 Mlig455_060625 {REF} {Length: 2190} {NoTransDecoderORF} {RNA1509_38113} {RNA1310_33283} {RNA815_55541}
46. MligTC455_30270 406 8.46 Mlig455_012719, Mlig455_044289

Neo: Int S/G2/M

Age: -

Regeneration-upregulated BL: 4.823

Regeneration-enriched BL: 4.823

 0.956 - - - - - 0.956

Mlig455_012719 {REF} {Length: 392} {RNA1509_16349} {RNA1310_2575}

Mlig455_044289 {REF} {Length: 4784} {RNA1509_16349} {RNA1310_2575} {RNA815_3500.1}
47. MligTC455_33511 496 10.33 Mlig455_019112

Neo: -

Age: -

Region-enriched R2: 2.637/0.00674

 INPP1 0.956 - - - - 0.956 - Mlig455_019112 {REF} {Length: 2860} {Pfam: Inositol monophosphatase family [PF00459.27, score=118.2]} {Human: ENSG00000151689, INPP1, inositol polyphosphate-1-phosphatase, [RH, Score=262, Expect=4e-83]} {Mouse: ENSMUSG00000026102, Inpp1, inositol polyphosphate-1-phosphatase, [RH, Score=297, Expect=7e-97]} {Dmel: FBgn0016672, Ipp, Inositol polyphosphate 1-phosphatase, [RH, Score=252, Expect=6e-80]} {Celegans: WBGene00044063, bpnt-1, 3'(2'), 5'-BisPhosphate NucleoTidase 1 homolog, [Score=74.7, Expect=1e-14]} {Smed: dd_Smed_v6_9612_0_1, dd_Smed_v6_9612_0_1, [RH, Score=197, Expect=6e-59]} {RNA1509_8591} {RNA1310_6898.1} {RNA815_7520}
48. MligTC455_03593 21 0.43 Mlig455_054695

Neo: -

Age: -

 0.955 0.955 - - - - - Mlig455_054695 {REF} {Length: 1093} {NoTransDecoderORF} {RNA1509_46835} {RNA1310_16754} {RNA815_21965}
49. MligTC455_44281 456 9.5 Mlig455_068996

Neo: -

Age: -

 ANPEP 0.955 - - - - - 0.955 Mlig455_068996 {REF} {Length: 3001} {Pfam: Peptidase family M1 domain [PF01433.22, score=209.7]; ERAP1-like C-terminal domain [PF11838.10, score=183.2]; Peptidase M1 N-terminal domain [PF17900.3, score=52.5]} {Human: ENSG00000166825, ANPEP, alanyl aminopeptidase, membrane, [Score=234, Expect=6e-66]; ENSG00000141279, NPEPPS, aminopeptidase puromycin sensitive, [Score=232, Expect=2e-65]; ENSG00000138792, ENPEP, glutamyl aminopeptidase, [Score=229, Expect=2e-64]; ENSG00000164308, ERAP2, endoplasmic reticulum aminopeptidase 2, [Score=228, Expect=9e-64]; ENSG00000164307, ERAP1, endoplasmic reticulum aminopeptidase 1, [Score=227, Expect=2e-63]} {Mouse: ENSMUSG00000001441, Npepps, aminopeptidase puromycin sensitive, [Score=232, Expect=4e-67]; ENSMUSG00000023845, Lnpep, leucyl/cystinyl aminopeptidase, [Score=226, Expect=5e-63]; ENSMUSG00000028024, Enpep, glutamyl aminopeptidase, [Score=226, Expect=2e-66]; ENSMUSG00000021583, Erap1, endoplasmic reticulum aminopeptidase 1, [Score=224, Expect=1e-62]; ENSMUSG00000039062, Anpep, alanyl (membrane) aminopeptidase, [Score=223, Expect=3e-62]} {Dmel: FBgn0039656, CG11951, [Score=283, Expect=1e-84]} {Celegans: WBGene00011587, T07F10.1, Aminopeptidase, [Score=215, Expect=1e-59]} {Smed: dd_Smed_v6_6470_0_1, dd_Smed_v6_6470_0_1, [Score=256, Expect=5e-74]} {RNA1509_48214, RNA1509_6569} {RNA1310_3710.1, RNA1509_48214} {RNA1509_48214, RNA815_5591.1}
50. MligTC455_17628 869 18.11 Mlig455_036459

Neo: -

Age: Down-Up-Up

 0.954 - - - - 0.954 - Mlig455_036459 {REF} {Length: 1261} {RNA1509_16798} {RNA1310_48718, RNA1509_16798} {RNA1509_16798, RNA815_24350}
51. MligTC455_24621 43 0.9 Mlig455_034366

Neo: -

Age: -

 0.954 - - - - - 0.954 Mlig455_034366 {REF} {Length: 575} {NoTransDecoderORF}
52. MligTC455_32436 43 0.91 Mlig455_025074

Neo: -

Age: -

 0.954 - - - - - 0.954 Mlig455_025074 {REF} {Length: 2851} {RNA1509_1845} {RNA1310_50.1} {RNA815_5933}
53. MligTC455_08889 26 0.54 Mlig455_054256

Neo: -

Age: -

 0.953 - - - - - 0.953 Mlig455_054256 {REF} {Length: 1360} {NoTransDecoderORF} {RNA1509_50721} {RNA1310_33163} {RNA815_21535}
54. MligTC455_25567 31 0.65 Mlig455_003495, Mlig455_015560, Mlig455_037973

Neo: -

Age: -

 GLRA4 0.953 - - - - - 0.953

Mlig455_003495 {REF} {Length: 2067} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=35.5]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=19.1]} {Human: ENSG00000188828, GLRA4, glycine receptor alpha 4, [Score=58.9, Expect=7e-09]; ENSG00000145451, GLRA3, glycine receptor alpha 3, [Score=58.2, Expect=1e-08]} {Mouse: ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [Score=58.2, Expect=1e-08]; ENSMUSG00000018595, Glra4, glycine receptor, alpha 4 subunit, [Score=57.4, Expect=2e-08]} {Dmel: FBgn0003011, ort, ora transientless, [Score=55.8, Expect=4e-08]} {Celegans: WBGene00015412, lgc-9, Ligand-Gated ion Channel, [Score=62.8, Expect=2e-10]} {Smed: dd_Smed_v6_14925_0_1, dd_Smed_v6_14925_0_1, [RH, Score=609, Expect=0.0]} {RNA1310_35073.1} {RNA815_40431}

Mlig455_015560 {REF} {Length: 1799} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=35.5]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=19.1]} {Human: ENSG00000188828, GLRA4, glycine receptor alpha 4, [Score=58.9, Expect=7e-09]; ENSG00000145451, GLRA3, glycine receptor alpha 3, [Score=58.2, Expect=1e-08]} {Mouse: ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [Score=58.2, Expect=1e-08]; ENSMUSG00000018595, Glra4, glycine receptor, alpha 4 subunit, [Score=57.4, Expect=2e-08]} {Dmel: FBgn0003011, ort, ora transientless, [Score=55.8, Expect=4e-08]} {Celegans: WBGene00015412, lgc-9, Ligand-Gated ion Channel, [Score=62.8, Expect=2e-10]} {Smed: dd_Smed_v6_14925_0_1, dd_Smed_v6_14925_0_1, [RH, Score=609, Expect=0.0]} {RNA1310_35073.1} {RNA815_40431}

Mlig455_037973 {REF} {Length: 1670} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=35.7]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=20.4]} {Human: ENSG00000188828, GLRA4, glycine receptor alpha 4, [Score=58.5, Expect=7e-09]; ENSG00000145451, GLRA3, glycine receptor alpha 3, [Score=57.4, Expect=2e-08]} {Mouse: ENSMUSG00000018595, Glra4, glycine receptor, alpha 4 subunit, [Score=57.4, Expect=1e-08]; ENSMUSG00000038257, Glra3, glycine receptor, alpha 3 subunit, [Score=57.4, Expect=1e-08]; ENSMUSG00000018589, Glra2, glycine receptor, alpha 2 subunit, [Score=54.7, Expect=1e-07]} {Dmel: FBgn0003011, ort, ora transientless, [Score=55.5, Expect=4e-08]} {Celegans: WBGene00015412, lgc-9, Ligand-Gated ion Channel, [Score=62.8, Expect=2e-10]} {Smed: dd_Smed_v6_14925_0_2, dd_Smed_v6_14925_0_2, [Score=554, Expect=0.0]} {RNA1310_35073.2} {RNA815_40431}
55. MligTC455_27846 65 1.35 Mlig455_062268

Neo: -

Age: -

 0.953 - - - - - 0.953 Mlig455_062268 {REF} {Length: 6610} {Pfam: RNase H-like domain found in reverse transcriptase [PF17919.3, score=128.3]; RNase H-like domain found in reverse transcriptase [PF17917.3, score=113.8]; Reverse transcriptase (RNA-dependent DNA polymerase) [PF00078.29, score=76.6]; Integrase zinc binding domain [PF17921.3, score=71.0]; Integrase core domain [PF00665.28, score=47.5]; Aspartyl protease [PF13650.8, score=38.9]; gag-polyprotein putative aspartyl protease [PF13975.8, score=34.5]; Retroviral aspartyl protease [PF00077.22, score=26.8]; Aspartyl protease [PF09668.12, score=22.8]; Putative peptidase (DUF1758) [PF05585.14, score=21.8]; Retroviral aspartyl protease [PF08284.13, score=18.9]; DDE superfamily endonuclease [PF13358.8, score=18.6]} {Smed: dd_Smed_v6_1574_6_41, dd_Smed_v6_1574_6_41, [Score=335, Expect=6e-100]} {RNA1509_20493} {RNA1310_131.1} {RNA815_52.1}
56. MligTC455_28182 212 4.43 Mlig455_030757, Mlig455_060379, Mlig455_066025

Neo: -

Age: -

 0.953 - - - - - 0.953

Mlig455_030757 {REF} {Length: 166} {NoTransDecoderORF} {RNA1310_4439.2} {RNA815_12729}

Mlig455_060379 {REF} {Length: 251} {NoTransDecoderORF} {RNA1310_4439.2} {RNA815_12729}

Mlig455_066025 {REF} {Length: 1610} {NoTransDecoderORF} {RNA1509_44500} {RNA1310_4439.1} {RNA815_1450.1}
57. MligTC455_09724 48 1.01 Mlig455_009261

Neo: -

Age: -

 0.952 - - - - - 0.952 Mlig455_009261 {REF} {Length: 1012} {NoTransDecoderORF}
58. MligTC455_11444 25 0.53 Mlig455_066854

Neo: -

Age: -

 0.952 - - - - - 0.952 Mlig455_066854 {REF} {Length: 845} {NoTransDecoderORF} {RNA1310_141915}
59. MligTC455_20478 52 1.08 Mlig455_031423

Neo: -

Age: -

 0.952 - - - - - 0.952 Mlig455_031423 {REF} {Length: 1562} {NoTransDecoderORF} {RNA1310_4910}
60. MligTC455_43540 65 1.36 Mlig455_063604

Neo: -

Age: -

 0.952 - - - - - 0.952 Mlig455_063604 {REF} {Length: 1048} {NoTransDecoderORF} {RNA1509_52081} {RNA1310_2648.1} {RNA815_12987}
61. MligTC455_49818 37 0.78 Mlig455_007221, Mlig455_007455

Neo: -

Age: -

 0.952 - - - - - 0.952

Mlig455_007221 {REF} {Length: 2050} {RNA1310_53527} {RNA815_61088}

Mlig455_007455 {REF} {Length: 3769} {Mouse: ENSMUSG00000054999, Naaladl1, N-acetylated alpha-linked acidic dipeptidase-like 1, [Score=56.6, Expect=8e-08]} {RNA1310_53527} {RNA815_58531}
62. MligTC455_11171 38 0.79 Mlig455_032767

Neo: -

Age: -

 0.951 - - - - - 0.951 Mlig455_032767 {REF} {Length: 428} {TRANSSPLICED}
63. MligTC455_20908 268 5.58 Mlig455_000262

Neo: -

Age: Up-Down-Down

 NALCN 0.951 - - - - - 0.951 Mlig455_000262 {REF} {Length: 6526} {TRANSSPLICED} {Pfam: Ion transport protein [PF00520.33, score=369.8]; Polycystin cation channel [PF08016.14, score=20.1]} {Human: ENSG00000102452, NALCN, sodium leak channel, non-selective, [Score=1434, Expect=0.0]} {Mouse: ENSMUSG00000000197, Nalcn, sodium leak channel, non-selective, [Score=1439, Expect=0.0]} {Dmel: FBgn0002917, na, narrow abdomen, [Score=1431, Expect=0.0]} {Celegans: WBGene00006809, unc-77, Four domain-type voltage-gated ion channel alpha-1 subunit, [Score=1234, Expect=0.0]} {Smed: dd_Smed_v6_7314_0_1, dd_Smed_v6_7314_0_1, [Score=1574, Expect=0.0]} {RNA1509_7317} {RNA1310_530.1} {RNA815_339.1}
64. MligTC455_25921 329 6.86 Mlig455_006703

Neo: -

Age: Down-Down-Down, logFC(26M/2M)=-2.996

Region-enriched R2: 6.614/0.00492

 0.951 - - - - 0.951 - Mlig455_006703 {REF} {Length: 664} {RNA1509_22927} {RNA1310_80445} {RNA815_41771.1}
65. MligTC455_38853 175 3.65 Mlig455_023629, Mlig455_057448

Neo: -

Age: Up-Down-Down

 0.951 - - - - - 0.951

Mlig455_023629 {REF} {Length: 364} {NoTransDecoderORF} {RNA1509_49659} {RNA1310_123644}

Mlig455_057448 {REF} {Length: 4350} {TRANSSPLICED} {NoTransDecoderORF} {RNA1509_57922} {RNA1310_17737.1} {RNA815_11419.1}
66. MligTC455_40658 152 3.17 Mlig455_064614

Neo: -

Age: -

 CLIP2 0.951 - - - - 0.951 - Mlig455_064614 {REF} {Length: 2460} {Pfam: CAP-Gly domain [PF01302.27, score=60.7]} {Human: ENSG00000106665, CLIP2, CAP-Gly domain containing linker protein 2, [Score=61.6, Expect=2e-09]} {Mouse: ENSMUSG00000063146, Clip2, CAP-GLY domain containing linker protein 2, [Score=62.0, Expect=9e-10]} {Dmel: FBgn0036882, CG9279, [Score=55.1, Expect=9e-08]} {Smed: dd_Smed_v6_12985_0_1, dd_Smed_v6_12985_0_1, [Score=56.2, Expect=2e-08]} {RNA1310_20676} {RNA815_40746}
67. MligTC455_42890 236 4.91 Mlig455_022504

Neo: -

Age: logFC(26M/2M)=-0.269

Region-enriched R4: 2.592/0.03886

 NOTCH1 0.951 - - - - - 0.951 Mlig455_022504 {REF} {Length: 3820} {Pfam: Calcium-binding EGF domain [PF07645.17, score=77.2]; EGF-like domain [PF00008.29, score=65.8]; Delta serrate ligand [PF01414.21, score=41.8]; Human growth factor-like EGF [PF12661.9, score=38.5]; EGF-like domain [PF07974.15, score=26.9]; EGF domain [PF12947.9, score=23.0]} {Human: ENSG00000148400, NOTCH1, notch 1, [Score=134, Expect=6e-32]; ENSG00000165124, SVEP1, sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1, [Score=132, Expect=2e-31]} {Mouse: ENSMUSG00000026923, Notch1, notch 1, [Score=130, Expect=5e-31]; ENSMUSG00000014773, Dll1, delta like canonical Notch ligand 1, [Score=129, Expect=6e-31]; ENSMUSG00000036766, Dner, delta/notch-like EGF repeat containing, [Score=127, Expect=3e-30]; ENSMUSG00000028369, Svep1, sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1, [Score=126, Expect=1e-29]; ENSMUSG00000027878, Notch2, notch 2, [Score=125, Expect=3e-29]} {Dmel: FBgn0004647, N, Notch, [Score=134, Expect=3e-32]} {Celegans: WBGene00018547, clec-78, C-type LECtin, [Score=119, Expect=2e-27]} {Smed: dd_Smed_v6_7067_0_1, dd_Smed_v6_7067_0_1, [Score=119, Expect=7e-28]} {RNA1509_36279} {RNA1310_12661} {RNA815_3995.1}
68. MligTC455_49072 2077 43.26 Mlig455_045808

Neo: -

Age: Down-Up-Up

Region-specific R2: 2.466

Region-enriched R2: 1.923/0.00002

 0.951 - - - - 0.951 - Mlig455_045808 {REF} {Length: 1508} {RNA1509_9056} {RNA1310_56777} {RNA815_24608}
69. MligTC455_50390 19 0.4 Mlig455_016912

Neo: -

Age: -

 CHRNA3 0.951 - - - - - 0.951 Mlig455_016912 {REF} {Length: 2944} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=242.1]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=157.8]} {Human: ENSG00000080644, CHRNA3, cholinergic receptor nicotinic alpha 3 subunit, [Score=326, Expect=7e-105]; ENSG00000274542, AC243734.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=317, Expect=2e-101]; ENSG00000175344, CHRNA7, cholinergic receptor nicotinic alpha 7 subunit, [Score=317, Expect=2e-101]; ENSG00000282088, AC254952.1, cholinergic receptor nicotinic alpha 7 subunit, [Score=313, Expect=5e-100]} {Mouse: ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=320, Expect=8e-103]; ENSMUSG00000030525, Chrna7, cholinergic receptor, nicotinic, alpha polypeptide 7, [Score=317, Expect=1e-101]; ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=315, Expect=2e-101]; ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=304, Expect=8e-97]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=347, Expect=1e-112]} {Celegans: WBGene00000060, acr-21, AcetylCholine Receptor, [RH, Score=307, Expect=1e-98]} {Smed: dd_Smed_v6_31300_0_1, dd_Smed_v6_31300_0_1, [RH, Score=539, Expect=0.0]} {RNA1310_33221} {RNA815_23594.2}
70. MligTC455_17966 1490 31.04 Mlig455_026737

Neo: -

Age: logFC(26M/2M)=-0.346

Region-specific R2: 3.759

Region-enriched R2: 2.729/0.00000
Region-enriched R6: 1.885/0.00048

Regeneration-downregulated R6: -2.271

Regeneration-depleted R6: -2.271

 0.95 - - - - 0.950 - Mlig455_026737 {REF} {Length: 1222} {Pfam: YqbF, hypothetical protein domain [PF14553.8, score=36.3]; Zinc-finger of nitric oxide synthase-interacting protein [PF15906.7, score=26.5]; Protein of unknown function (DUF559) [PF04480.14, score=20.7]; REase_MTES_1575 [PF18741.3, score=20.0]} {RNA1509_18273} {RNA1310_34603.1} {RNA815_20381}
71. MligTC455_40137 98 2.05 Mlig455_060068

Neo: -

Age: -

Region-enriched R2: 4.909/0.02205
Region-enriched R3: 3.123/0.04741

 IDNK 0.95 - - - - - 0.950 Mlig455_060068 {REF} {Length: 2173} {TRANSSPLICED} {Pfam: Shikimate kinase [PF01202.24, score=36.3]; AAA domain [PF13671.8, score=30.7]; AAA domain [PF13238.8, score=26.4]; AAA domain [PF13521.8, score=24.3]; ATPase family associated with various cellular activities (AAA) [PF00004.31, score=21.5]; AAA domain [PF13207.8, score=20.8]} {Human: ENSG00000148057, IDNK, IDNK, gluconokinase, [RH, Score=126, Expect=2e-36]} {Mouse: ENSMUSG00000050002, Idnk, idnK gluconokinase homolog (E. coli), [RH, Score=132, Expect=3e-39]} {Celegans: WBGene00017818, F26D11.1, Gluconokinase, [RH, Score=127, Expect=2e-37]} {Smed: dd_Smed_v6_14936_0_1, dd_Smed_v6_14936_0_1, [RH, Score=108, Expect=2e-30]} {RNA1509_45489, RNA1509_48460} {RNA1310_24189, RNA1509_45489} {RNA1509_45489, RNA815_32058}
72. MligTC455_49358 121 2.52 Mlig455_036395, Mlig455_042887

Neo: -

Age: -

Region-enriched R5: 3.321/0.01476

 0.95 - - - - - 0.950

Mlig455_036395 {REF} {Length: 707} {NoTransDecoderORF} {RNA1310_119277}

Mlig455_042887 {REF} {Length: 657} {NoTransDecoderORF} {RNA1310_119277}
73. MligTC455_49527 147 3.06 Mlig455_027843

Neo: -

Age: -

 0.95 - - - - - 0.950 Mlig455_027843 {REF} {Length: 1796} {RNA1509_15103} {RNA1310_101911} {RNA815_59080}

Refine r cutoff to:    Show

Berezikov Lab - 2020-2021 © ERIBA